Research projects

  • Therapeutic drug monitoring of TNFinhibitors and other therapeutic antibodies.
  • Develop assays for novel immunotherapy drugs such as pembrolizumab, nivolumab and  ipilimumab for monitoring drug levels in patients with lung cancer and malignant melanoma.
  • Develop assays for measuring rituximab and anti-rituximab for monitoring drug level and anti-drug antibody formation.
  • Detection of antibodies to transglutaminase in the HUNT4-cohort using an in-house dual label assay in collaborative study “Coeliac disease in HUNT”.
  • Screening for patient antibodies to HH1, a novel antibody-based drug used in lymphoma clinical trials (Lymrit).
 
Page visits: 2021